PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32606154-10	2020	In melanoma-bearing mice, cisplatin alone decreased the activity of NK cells and the levels of IL-2 and IFN-gamma, which were effectively restored by the combination of MH-30 with cisplatin.	Cisplatin	26-35	interleukin 2	Mus musculus	95-99	
32606154-10	2020	In melanoma-bearing mice, cisplatin alone decreased the activity of NK cells and the levels of IL-2 and IFN-gamma, which were effectively restored by the combination of MH-30 with cisplatin.	Cisplatin	180-189	interleukin 2	Mus musculus	95-99	
28655574-5	2018	Our previous studies have shown that treatment of L. donovani infected mice with cisplatin along with herbal drugs resulted in decreased parasite load with heightened delayed type hypersensitivity responses (DTH), increased levels of IgG2a, IFN-gamma, IL-2, CD4+ cells, NK 1.1 cells over that of IgG1, IL-4, 1L-10, CD8+ and CD19 in infected mice.	Cisplatin	81-90	interleukin 2	Mus musculus	252-256	
19292900-12	2009	In melanoma-bearing mice treated with cisplatin, HemoHIM administration also increased the activity of NK cells and Tc cells and the IL-2 and IFN-gamma secretion from splenocytes, which seemed to contribute to the enhanced efficacy of cisplatin by HemoHIM.	Cisplatin	38-47	interleukin 2	Mus musculus	133-137	
22714286-9	2012	IL-2 treatment during chemotherapy refocused the response to SIINFEKL and simultaneously degraded the cisplatin-driven subdominant CTL response.	Cisplatin	102-111	interleukin 2	Mus musculus	0-4	
3501452-3	1987	When a combination chemotherapy which consisted of cisplatin, adriamycin and cyclophosphamide was given to these ovarian cancer patients, the OKT 4/8 cell ratio was significantly increased while the IL-2 production was markedly inhibited.	Cisplatin	51-60	interleukin 2	Mus musculus	199-203	
9520291-0	1998	Interleukin-2: hope in cases of cisplatin-resistant tumours.	Cisplatin	32-41	interleukin 2	Mus musculus	0-13	
9024501-10	1996	When G-CSF or IL-2 was combined with cisplatin, the suppression by cisplatin was eliminated and subsequently resulted in a prolongation of the survival time.	Cisplatin	67-76	interleukin 2	Mus musculus	14-18	
7923989-2	1994	The combination of interferon-beta and interleukin-2 after treatment with etoposide or cisplatin exerted profound therapeutic effects in an experimental model (lung colonization) using colon carcinoma 26, which was resistant to interferon-beta or to interleukin-2 alone.	Cisplatin	87-96	interleukin 2	Mus musculus	39-52	
8509227-0	1993	Dualistic effects of cis-diammine-dichloro-platinum on the anti-tumor efficacy of subsequently applied recombinant interleukin-2 therapy: a tumor-dependent phenomenon.	Cisplatin	21-51	interleukin 2	Mus musculus	115-128